|Authors: (Juraj Majtan, Martin Cernak, Nora Majtanova and Andrej Cernak)|
Currently, honey is considered to be a therapeutic agent, and its successful application in the treatment of chronic wounds and burns has promoted its further clinical use for treating various disorders, including eye disorders. There exists some evidence that honey may be helpful in treating dry eye disease, age-related macular degeneration, cataracts and bullous keratopathy. Furthermore, it can be used as an antibacterial agent against resistant ocular pathogens that can negatively affect eye health.
This chapter discusses the current knowledge and new perspectives for honey therapy in ophthalmology. In addition, we report a patient with a corneal ulcer in whom conventional medical therapy had failed. In this case, honey eyedrops (25% honeydew honey) were used to treat lens-related bacterial keratitis in a 32 year old man. We found that honey was able to inhibit Pseudomonas aeruginosa ocular isolates and completely reduced pain and itching in the affected eye.
Taken together, honey is a promising ophthalmological agent. However, we advocate randomised controlled trials to determine the efficacy and safety of honey in ophthalmology.